KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Accounts Payables (2019 - 2026)

GoodRx Holdings' Accounts Payables history spans 7 years, with the latest figure at $19.4 million for Q4 2025.

  • On a quarterly basis, Accounts Payables rose 37.26% to $19.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.4 million, a 37.26% increase, with the full-year FY2025 number at $19.4 million, up 37.26% from a year prior.
  • Accounts Payables hit $19.4 million in Q4 2025 for GoodRx Holdings, down from $28.7 million in the prior quarter.
  • Over the last five years, Accounts Payables for GDRX hit a ceiling of $36.3 million in Q4 2023 and a floor of $6.8 million in Q2 2023.
  • Historically, Accounts Payables has averaged $19.0 million across 5 years, with a median of $17.1 million in 2021.
  • Biggest five-year swings in Accounts Payables: skyrocketed 203.13% in 2023 and later plummeted 62.34% in 2024.
  • Tracing GDRX's Accounts Payables over 5 years: stood at $17.5 million in 2021, then grew by 1.14% to $17.7 million in 2022, then surged by 104.89% to $36.3 million in 2023, then crashed by 61.02% to $14.1 million in 2024, then soared by 37.26% to $19.4 million in 2025.
  • Business Quant data shows Accounts Payables for GDRX at $19.4 million in Q4 2025, $28.7 million in Q3 2025, and $25.4 million in Q2 2025.